Uboldi, S <br/><br/>
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.  [electronic resource] 

 -  International journal of cancer  Jul 2012 
 - 59-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.26340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis<br/>C-Reactive Protein--genetics<br/>CCAAT-Enhancer-Binding Protein-alpha--genetics<br/>CCAAT-Enhancer-Binding Protein-beta--genetics<br/>Cell Line, Tumor<br/>DNA Methylation<br/>DNA Modification Methylases--deficiency<br/>DNA Repair<br/>DNA Repair Enzymes--deficiency<br/>Dacarbazine--analogs & derivatives<br/>Dioxoles--pharmacology<br/>Drug Resistance, Neoplasm<br/>Fibronectins--genetics<br/>Humans<br/>Liposarcoma, Myxoid--drug therapy<br/>Oncogene Proteins, Fusion--genetics<br/>Promoter Regions, Genetic<br/>RNA-Binding Protein FUS--genetics<br/>Serum Amyloid P-Component--genetics<br/>Signal Transduction<br/>Temozolomide<br/>Tetrahydroisoquinolines--pharmacology<br/>Trabectedin<br/>Transcription Factor CHOP--genetics<br/>Tumor Suppressor Proteins--deficiency<br/>Ultraviolet Rays